279 related articles for article (PubMed ID: 11779429)
1. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z
Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
3. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
Nakazato T; Ito K; Ikeda Y; Kizaki M
Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
Zhou Y; Huang X; Cai X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):181-3. PubMed ID: 11783079
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH
Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676
[TBL] [Abstract][Full Text] [Related]
8. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Lee YY; Kim BK
Int J Oncol; 2001 Feb; 18(2):249-55. PubMed ID: 11172589
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
10. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.
Haga N; Fujita N; Tsuruo T
Cancer Sci; 2005 Nov; 96(11):825-33. PubMed ID: 16271077
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
14. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
Rojewski MT; Körper S; Thiel E; Schrezenmeier H
Oncol Rep; 2004 Feb; 11(2):509-13. PubMed ID: 14719092
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
[TBL] [Abstract][Full Text] [Related]
18. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
